University of Michigan

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).

1,327 total trials 179 currently recruiting 971 completed early-phase tilt top decile by trial count

University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.

University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.

Top-decile sponsor footprint

University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 64/100

971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,327 total, page 21 of 27

COMPLETED

Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy

NCT02039310

COMPLETED Phase 2

A Randomized Control Trial of Sun Protection Interventions for Operating Engineers

NCT01804595

TERMINATED Phase 4

Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section

NCT01528696

COMPLETED NA

Health Explorer - Optimizing Alcohol Brief Interventions

NCT01370226

COMPLETED Phase 3

Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurological Intensive Care

NCT01495429

COMPLETED NA

Is Eovist Suitable for Arterial-Phase MR Imaging of Liver

NCT02684526

TERMINATED Phase 2

A Clinical Trial for CTD-ILD Treatment

NCT01424033

COMPLETED NA

A Study of Exclusion Criteria in a University Population

NCT01472536

COMPLETED

Monocyte Phenotypic Changes in Heart Failure

NCT02997462

COMPLETED Phase 2

Pilot Study to Determine Effects of Salsalate in Type 1 Diabetes and Painful Peripheral Neuropathy

NCT01480297

COMPLETED NA

Evaluation of Bone Length Measurement

NCT02165527

COMPLETED

Sensory Sensitivity and Urinary Symptoms in the Female Population

NCT01978002

COMPLETED Phase 1

Distribution of Rubidium-82, Nitrogen-13 Ammonia, and Fluorine-18 Fluorodeoxyglucose in Normal Volunteers

NCT01433705

COMPLETED NA

Psychosocial Pain Management During Addictions Treatment to Improve Outcomes

NCT01372267

COMPLETED NA

MPOWERed Messages: Tailored Mobile Messages to Enhance Weight Loss for Teens

NCT01448551

COMPLETED Phase 4

Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients

NCT01435174

COMPLETED NA

Mindfulness Mediation Intervention in Chronic Obstructive Pulmonary Disease (COPD)

NCT01577329

COMPLETED Phase 2

Adenosine to Assess Complete Conduction Block During Catheter Ablation of Paroxysmal Atrial Fibrillation

NCT03032965

COMPLETED NA

Home-Based Diagnosis and Management of Sleep-Related Breathing Disorders in Spinal Cord Injury

NCT01882257

COMPLETED

Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma

NCT01511653

COMPLETED Phase 4

Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars

NCT01496846

COMPLETED NA

Brain as a Therapeutic and Research Target in Trigeminal Neuropathic Pain

NCT03003715

COMPLETED

Relationship Between Systemic Fatty Acid Availability and Insulin Sensitivity

NCT01452048

COMPLETED Phase 2

Mom Power is an Attachment Based Parenting Program for Families and Their Children

NCT01554215

COMPLETED NA

iDecide.Decido: Diabetes Medication Decision Support Study

NCT01427660

TERMINATED NA

The Effect of Losartan in Bicuspid Aortic Valve Patients

NCT01390181

COMPLETED NA

Prophylactic Application of an Incisional Wound Vac to Prevent Wound Complications in Obese Spine Surgery Patients

NCT02926924

COMPLETED

Mastectomy Reconstruction Outcomes Consortium (MROC) Study

NCT01723423

COMPLETED NA

Glutathione and Health With Post-Polio Syndrome

NCT01402570

COMPLETED NA

Lifestyle Physical Activity for People With COPD

NCT01856231

TERMINATED NA

Bolus Versus Continuous Feeding Regimens Post Gastrostomy Tube Placement

NCT02006953

COMPLETED NA

Youth Empowerment Solutions for Positive Youth Development

NCT01884090

COMPLETED Phase 4

Dissemination of Tobacco Tactics for Hospitalized Smokers

NCT01309217

COMPLETED NA

Progressive Metabolic Adaptations to Low Intensity Exercise Training and Weight Loss

NCT01452074

COMPLETED

PET Imaging Study of Neurochemical and Autonomic Disorders in Multiple System Atrophy (MSA)

NCT02035761

TERMINATED Phase 1

Prospective L-arginine Study

NCT01485757

TERMINATED NA

Acupressure for Insomnia

NCT01378793

COMPLETED

Long-term LASIK Follow up Study

NCT01695642

COMPLETED NA

Making Decisions About the Measles-Mumps-Rubella Vaccine

NCT01369394

COMPLETED NA

The Effect of Platform Switching on Single Implants in the Esthetic Zone, Following Flapless Surgery and Early-Loading Protocols

NCT02173236

COMPLETED

The Importance of Periostin in Periodontal Health and Disease

NCT01180920

COMPLETED

Imaging Based Dosimetry for Individualized Internal Emitter Therapy

NCT01988272

COMPLETED NA

Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams

NCT00738712

COMPLETED NA

Comparative Effectiveness of MR Enterography

NCT01593462

COMPLETED NA

Stroke Health and Risk Education (SHARE)

NCT01378780

TERMINATED NA

Transcranial Magnetic Stimulation for the Treatment of Auditory Hallucinations in Schizophrenia

NCT01595503

COMPLETED NA

Biospecimens for Identification of Diseases of the Pancreas.

NCT01392027

COMPLETED Phase 2

Acupressure for Persistent Cancer Related Fatigue

NCT01281904

COMPLETED NA

Mindfulness and Present Centered Therapies for PTSD: Efficacy and Mechanisms

NCT01347749

COMPLETED NA

Enhancing Self Regulation as a Strategy for Obesity Prevention in Head Start Preschoolers

NCT01398358

← Previous Page 21 of 27 Next →

Phase Distribution

PhaseTrial count
Phase 1 79
Phase 2 80
Phase 3 25
Phase 4 69

What is open in the University of Michigan pipeline

179 recruiting of 1,327 indexed (13% open); 971 completed (73%).

Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).

Top condition: Depression (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Michigan: open-pipeline peers nationwide

Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 0%5%10%15%20%25% Total trials Recruiting share University of MichiganEli Lilly and CompanyGlaxoSmithKlineAstraZenecaUniversity of Colorado, DenverWayne State UniversityCase Comprehensive Cancer CenterAlbany Medical CollegeTaiho Oncology
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,327 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this University of Michigan page

1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.

  • 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.